Clinical symptom screening kit

Abstract

The utility model discloses a clinical symptom screening kit which comprises a detection box, a light hole, a reagent bottle, a cotton swab, a bottle cap, an upper cover, a bottom cover, detection test paper, an extrusion groove, a reagent dripping inlet and a window, the detection box comprises the upper cover and the bottom cover, and the reagent dripping inlet and the window are formed in the front and the back of the upper side of the outer portion of the upper cover respectively. A light hole is formed in the lower end of the outer part of the bottom cover, test paper is arranged in the upper cover, the kit further comprises a reagent bottle, a cotton swab and a bottle cap, the bottle cap can be sleeved on the cotton swab, and an extrusion groove is formed in the inner wall of the reagent bottle. Compared with the prior art, the detection kit has the advantages that the detection result of the detection test paper can be conveniently observed through a light source opposite to the back of the detection kit, the result is more convenient and effective to read, and cotton swabs and reagents after sampling can be conveniently and uniformly mixed.

Description

Technical Field

[0001] The utility model relates to the technical field of clinical symptom screening, in particular to a clinical symptom screening kit. Background Technique

[0002] During the process of clinical symptom screening and detection, kits are needed. When detecting symptoms in the department of cardiovascular medicine, for diseases that induce arrhythmia such as myocarditis and myocardial infarction, kits for detecting cardiac troponin, creatine kinase isoenzyme, myoglobin detection kits, etc. are usually required. Among them, viral myocarditis is a relatively common causative factor for inducing arrhythmia, often caused by viral infections, such as concurrent symptoms of colds, diarrhea, inflammation, fever, etc. It is necessary to conduct pathogen detection. After sampling the patient and mixing it with the detection reagent, the test paper is titrated to determine whether the test result is positive or negative. The detection is relatively convenient, easy to operate, and convenient to promptly discover the causative factor of arrhythmia according to the test result at an early stage, so as to carry out timely treatment.

[0003] A sialic acid detection kit described in the patent publication number CN219173082U includes a reagent card and a transfer cylinder. The surface of the reagent card is provided with a display area and a collection area. The display area is located on one side of the collection area. A protective structure is arranged on the surface of the reagent card at the collection area. The protective structure includes a rotating plate. One end of the rotating plate is provided with a rotating hole, and the other end of the rotating plate is provided with two clamping pins. A rotating pin is arranged on the surface of the reagent card at one end of the collection area. For the sialic acid detection kit of the present utility model, the rotating plate covers the surface of the collection area, which can prevent dust or water stains from entering the collection area, reduce the pollution at the collection area when waiting for the result at the display area, and make the reaction between the reagent and the test solution to be detected in the reagent card and the test paper more accurate. When pouring the reaction reagent into the transfer cylinder, the transfer cylinder can be prevented from tipping over. Placing the transfer cylinder in the fixing hole for fixation is convenient for later operation and does not affect normal operation.

[0004] The information disclosed in this background art section is only intended to enhance the overall understanding of the present invention and should not be regarded as an admission or any form of suggestion that this information constitutes prior art already known to those of ordinary skill in the art.

[0005] Although the above detection kit solves certain problems, it still has the following disadvantages:

[0006] (1) After sampling and dropping the reagent after dissolving the sample onto the kit, if the patient's symptoms are not obvious or the indication on the test paper of the test result is not obvious due to factors such as the detection time, the degree of presentation of the test paper, and other reasons, it is difficult to judge the test result.

[0007] (2) After inserting the cotton swab into the vial containing the detection reagent during sampling, since the inner wall of the vial is relatively smooth, the cotton head on the swab can only mix the reagent and the sample by breaking and soaking, resulting in a relatively long time to mix evenly or difficult to mix evenly, which affects the detection result. Summary of the Invention

[0008] The purpose of the present utility model is to provide a clinical symptom screening kit.

[0009] To achieve the above purpose, the present utility model is realized through the following technical solutions:

[0010] A clinical symptom screening kit, comprising:

[0011] A detection box, which is composed of an upper cover and a bottom cover. The upper cover is located above the bottom cover. A test strip is arranged on the upper side inside the upper cover. A reagent dropping port is opened on the front side of the upper end outside the upper cover. A window for cooperating with the test strip is opened on the rear side outside the reagent dropping port at the upper end of the upper cover;

[0012] A light-transmitting hole, which is opened at the lower end outside the bottom cover, and the light-transmitting hole is adapted to the window. On both sides of the upper edge outside the light-transmitting hole at the lower end inside the bottom cover, support plates for cooperating with the test strip are fixedly connected. A transparent acrylic thin plate is arranged between the support plates;

[0013] A reagent bottle, which is in the same package as the detection box. An extrusion groove is opened on the inner wall of the reagent bottle, and the inner wall of the extrusion groove is rough. The upper end opening of the reagent bottle is sealed by a sealing label;

[0014] A cotton swab, which is in the same package as the detection box. One end of the cotton swab connected to the cotton ball is relatively easy to break, and the cotton ball on the cotton swab is adapted to the extrusion groove;

[0015] A bottle cap, which is in the same package as the reagent bottle and is adapted to the reagent bottle. The bottle cap can be sleeved on the cotton swab through the bottle cap nozzle.

[0016] Furthermore, sealing gaskets are fixedly connected to the front and rear of the upper end inside the upper cover and the edges on both sides of the lower end outside the window. The test strip is pasted on the upper end inside the upper cover through the sealing gaskets.

[0017] Furthermore, the front and rear of the lower side of the transparent acrylic thin plate are adhered to the front and rear of the lower end inside the bottom cover.

[0018] Furthermore, one end of the cotton swab connected to the cotton ball is relatively thin, and the other end of the swab handle of the cotton swab connected to the cotton ball is relatively thick.

[0019] Furthermore, the reagent bottle can scrape the sample on the cotton swab through the extrusion groove.

[0020] The utility model provides a clinical symptom screening kit, which has the following beneficial effects:

[0021] (1) By opening a light-transmitting hole on the back of the test box and using a transparent acrylic plate to block it, it is convenient for lighting. By facing the light-transmitting hole towards the light source, the presented result of the test paper can be observed, and the read result is more accurate and the presented result is clearer.

[0022] (2) By opening a groove with a rough surface on the inner wall of the vial for placing the reagent, it assists in mixing the sample dipped on the cotton swab and the reagent. Finally, the cotton head of the cotton swab is broken and mixed with the reagent, which aids in the mixing of the sampled materials, accelerates the mixing of the reagent and the sample, increases the degree of mixing uniformity, and ensures the accuracy of the test result. When stirring the cotton swab, the bottle cap is placed on the reagent bottle, and the internal reagent is not easily spilled. Description of the Drawings

[0023] In order to more clearly illustrate the embodiments of the present utility model or the technical solutions in the prior art, the following will briefly introduce the drawings required for use in the description of the embodiments or the prior art. Obviously, the drawings described below are only exemplary, and for those of ordinary skill in the art, without creative efforts, other implementation drawings can also be obtained based on the provided drawings.

[0024] Figure 1 is a three-dimensional view of a clinical symptom screening kit of the present utility model.

[0025] Figure 2 is a three-dimensional view of a partial structure of a clinical symptom screening kit of the present utility model Figure 1 .

[0026] Figure 3 is a three-dimensional view of a partial structure of a clinical symptom screening kit of the present utility model Figure 2 .

[0027] Figure 4 is a three-dimensional view of a partial structure of a clinical symptom screening kit of the present utility model Figure 3 .

[0028] Figure 5 is a three-dimensional view of a partial structure of a clinical symptom screening kit of the present utility model Figure 4 .

[0029] Figure 6 is a three-dimensional view of a partial structure of a clinical symptom screening kit of the present utility model Figure 5 .

[0030] Figure 7It is a three-dimensional view of a partial structure of a clinical symptom screening kit of the present utility model Figure 6 .

[0031] Labels in the figure: 1. Detection box; 2. Light-transmitting hole; 3. Reagent bottle; 4. Cotton swab; 5. Bottle cap; 6. Upper cover; 7. Bottom cover; 8. Detection test strip; 9. Reagent dropping port; 10. Window; 11. Support plate; 12. Acrylic thin plate; 13. Extrusion groove; 14. Sealing label; 15. Sealing gasket. Detailed implementation manners

[0032] Here, the exemplary embodiments will be described in detail, and the examples are shown in the accompanying drawings. When the following description refers to the accompanying drawings, unless otherwise indicated, the same numbers in different drawings represent the same or similar elements. The implementation manners described in the following exemplary embodiments do not represent all implementation manners consistent with the present disclosure. On the contrary, they are merely examples of devices consistent with some aspects of the present disclosure as detailed in the appended claims.

[0033] Next, the technical solutions in the embodiments of the present utility model will be clearly and completely described in conjunction with the accompanying drawings in the embodiments of the present utility model. All other embodiments obtained by those of ordinary skill in the art based on the embodiments of the present utility model without creative efforts shall fall within the protection scope of the present utility model.

[0034] Embodiment 1:

[0035] As Figures 1 to 7 shown, this embodiment proposes a clinical symptom screening kit, including a detection box 1, a light-transmitting hole 2, a reagent bottle 3, a cotton swab 4, a bottle cap 5, an upper cover 6, a bottom cover 7, a detection test strip 8, a reagent dropping port 9, and a window 10 for viewing and comparing the detection structure display of the detection test strip 8.

[0036] Among them, inside the package of the same detection box, there are a detection box 1, a reagent bottle 3 made of soft transparent plastic, a cotton swab 4 with a long handle, and a bottle cap 5 used to block the reagent bottle 3. The detection box 1 is composed of an upper cover 6 and a bottom cover 7. A circular reagent dropping port 9 is opened on the front side of the upper end of the outside of the upper cover 6. Starting from the outside rear side of the reagent dropping port 9, a long strip-shaped window 10 is opened at the upper end inside the upper cover 6. On the upper end inside the upper cover 6, on both sides of the lower edge of the outside of the window 10, and at the front and back of the upper end inside the upper cover 6, sealing gaskets 15 are fixedly connected. A detection test strip 8 is arranged inside the upper cover 6. The detection test strip 8 is pasted on the upper end inside the upper cover 6 through the sealing gasket 15. The window 10 is convenient for observing the changes after the sampling reagent is dropped on the detection test strip 8.

[0037] A light-transmitting hole 2 is opened at the lower end of the outer part of the bottom cover 7. The light-transmitting hole 2 coincides with the window 10. On both sides of the upper edge of the upper end of the light-transmitting hole 2 inside the bottom cover 7, support plates 11 are fixedly connected. The upper ends of the support plates 11 press the test strip 8 upward against the sealing gasket 15. A transparent acrylic thin plate 12 is arranged between the support plates 11. The front and back of the lower end of the acrylic thin plate 12 are adhesively bonded to the front and back of the upper end inside the bottom cover 7 respectively to protect the inside of the test box 1 through the acrylic thin plate 12.

[0038] After dropping the reagent dissolved with the test sample into the reagent dropping port 9, the test strip 8 changes. Sometimes the indication of whether it is positive is not obvious. The back of the test box 1 can be irradiated with light. The light-transmitting hole 2 and the acrylic thin plate 12 transmit light and irradiate the back of the test strip 8, which is convenient to more clearly observe the change of the test strip 8 from the window 10.

[0039] In the state of normal packaging and unused, the bottle mouth of the reagent bottle 3 in the same packaging as the test box 1 is sealed by an aluminum sealing label 14. There is also a bottle cap 5 inside the packaging. After tearing the sealing label 14, the bottle cap 5 can be used to cover the bottle mouth. It is convenient to drop the reagent to be tested into the reagent dropping port 9 through the bottle cap nozzle of the bottle cap 5. The cotton swab 4 inside the packaging has a thick end at the end of the handle away from the cotton ball and a thin end at the end connecting the cotton ball. And the end of the cotton swab 4 connecting the cotton ball is connected by a very thin and easily breakable plastic rod. The cotton swab 4 can pass through the inside of the bottle cap 5 with the end of the cotton ball, making the bottle cap nozzle of the bottle cap 5 face away from the cotton ball. Use the cotton ball of the cotton swab 4 to dip into the potential virus sites such as nasal secretions, feces or throat of the arrhythmogenic virus detection sample for sampling. Then insert the cotton ball of the cotton swab 4 with the sample into the reagent bottle 3 with the sealing label 14 torn (as Figure 3 shown). After covering the bottle cap 5 on the reagent bottle 3, move the cotton ball of the cotton swab 4 to the position of the extrusion groove 13, squeeze the reagent bottle 3 and stir the cotton swab 4 to make the cotton ball scrape against the inner wall of the extrusion groove 13. The cotton swab 4 blocks the bottle cap nozzle of the bottle cap 5 to prevent the reagent from leaking. Finally, break the cotton ball off the cotton swab 4 and soak it in the reagent bottle 3.

[0040] Shake the reagent and the sample in the reagent bottle 3 evenly. Use the bottle cap nozzle of the bottle cap 5 to drop the mixed reagent from the reagent dropping port 9 onto the test paper. After the test paper changes, align the light-transmitting hole 2 with the light source and irradiate the back of the test paper. Observe the indications at the C (negative) and T (positive) positions outside the upper cover 6 to distinguish whether the clinical symptom test result is positive or negative. After use, put all the test items into the isolation bag for sealing and centralized collection and treatment.

[0041] All the electrical components appearing in this article are electrically connected to the external main controller and the 220V mains power supply. The main controller can be a conventional known device such as a computer for control. In the specific implementation manners of the present disclosure, the detailed descriptions of known functions and known components are omitted. To ensure the compatibility of the device, the operation means adopted are consistent with the parameters of market instruments.

[0042] Although the embodiments of the present invention have been shown and described, those of ordinary skill in the art can understand that various changes, modifications, substitutions, and variations can be made to these embodiments without departing from the principles and spirit of the present invention. The scope of the present invention is defined by the appended claims and their equivalents.

Claims

1. A clinical symptom screening kit, characterized in that: Comprising: A detection box (1), the detection box (1) is composed of an upper cover (6) and a bottom cover (7), the upper cover (6) is located on the upper side of the bottom cover (7), a detection test strip (8) is arranged on the upper side inside the upper cover (6), a reagent dropping port (9) is opened on the front side of the upper end outside the upper cover (6), and a window (10) for cooperating with the detection test strip (8) is opened on the rear side outside the reagent dropping port (9) at the upper end outside the upper cover (6); A light-transmitting hole (2), the light-transmitting hole (2) is opened at the lower end outside the bottom cover (7), and the light-transmitting hole (2) is adapted to the window (10). On both sides of the upper edge outside the light-transmitting hole (2) at the lower end inside the bottom cover (7), support plates (11) for cooperating with the detection test strip (8) are fixedly connected, and a transparent acrylic thin plate (12) is arranged between the support plates (11); A reagent bottle (3), the reagent bottle (3) and the detection box (1) are in the same package. An extrusion groove (13) is opened on the inner wall of the reagent bottle (3), the inner wall of the extrusion groove (13) is rough, and the upper end opening of the reagent bottle (3) is sealed by a sealing label (14); A cotton swab (4), the cotton swab (4) and the detection box (1) are in the same package. One end of the cotton swab (4) connected to the cotton ball is relatively easy to break, and the cotton ball on the cotton swab (4) is adapted to the extrusion groove (13); A bottle cap (5), the bottle cap (5) and the reagent bottle (3) are in the same package, and the bottle cap (5) is adapted to the reagent bottle (3). The bottle cap (5) can be sleeved on the cotton swab (4) through the bottle cap nozzle.

2. The clinical symptom screening kit according to claim 1, wherein: Sealing rubber pads (15) are fixedly connected to the front and rear of the upper end inside the upper cover (6) and the edges on both sides of the lower end outside the window (10). The detection test strip (8) is pasted on the upper end inside the upper cover (6) through the sealing rubber pads (15).

3. The clinical symptom screening kit according to claim 1, wherein: The lower front and rear of the transparent acrylic thin plate (12) are adhesively bonded to the lower front and rear of the inside of the bottom cover (7).

4. The clinical symptom screening kit according to claim 1, wherein: One end of the cotton swab (4) connected to the cotton ball is thinner, and the other end of the handle of the cotton swab (4) connected to the cotton ball is thicker.

5. A clinical symptom screening kit according to claim 1, characterized in that: The reagent bottle (3) can scrape the sample on the cotton swab (4) through the extrusion groove (13).

Images